Search Within

Jedd D Wolchok

Formats
  1. Journal Article (450)
  2. Meeting Abstract (414)
  3. Book Section (19)
  4. Editorial (9)
  5. Review (5)
  6. Correspondence (3)
  7. Research Letter (3)
  8. Book Whole (1)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (905)
  2. GSK Faculty (905)
  3. Melanoma and Immunotherapeutics Service (905)
  4. Solid Tumor Oncology Division (905)
  5. Melanoma Disease Management Team (222)
  6. Sloan Kettering Institute Postdocs (195)

More Groups

People
  1. Taha Merghoub (230)
  2. Michael Postow (158)
  3. Alan Houghton (118)
  4. Margaret Callahan (113)
  5. Paul Chapman (107)
  6. Katherine Panageas (92)

More People

Years
  1. 2024 (2)
  2. 2023 (15)
  3. 2022 (46)
  4. 2021 (42)
  5. 2020 (46)
  6. 2019 (47)

More Years

Publications
  1. Journal of Clinical Oncology (171)
  2. Journal for ImmunoTherapy of Cancer (81)
  3. Cancer Research (59)
  4. Clinical Cancer Research (35)
  5. Annals of Oncology (34)
  6. European Journal of Cancer (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (171)
  2. American Association for Cancer Research (130)
  3. Biomed Central Ltd (83)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (52)
  6. Oxford University Press (44)

More Publishers

Results (905)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
    Journal Article

    Widman, A. J.; Shah, M.; Frydendahl, A.; Halmos, D.; Khamnei, C. C.; Øgaard, N.; Rajagopalan, S.; Arora, A.; Deshpande, A.; Hooper, W. F.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Surgical stress promotes IL-6-driven tumor progression in ovarian cancer
    Meeting Abstract

    Praiss, A.; Longhini, A. L. F.; Pesci, G.; Green, H.; Ozsoy, M.; Kahn, R.; Brodeur, M.; Bhaloo, S.; Merghoub, T.; Wolchok, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of tumor metabolism on the microenvironment and response to immunotherapy
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Brunschvig, S.; Santhella, A.; Mane, M.; Vemuri, K.; Ijoma, J.; Kang, W.; Manovatodorova, K.; Koutcher, J.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib
    Meeting Abstract

    Chapman, P. B.; Klang, M.; Postow, M. A.; Shoushtari, A. N.; Sullivan, R. J.; Wolchok, J. D.; Wong, P.; Callahan, M. K.; Zippin, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save